Modivcare Stock Performance
MODV Stock | USD 17.76 0.03 0.17% |
The company secures a Beta (Market Risk) of 0.35, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, ModivCare's returns are expected to increase less than the market. However, during the bear market, the loss of holding ModivCare is expected to be smaller as well. At this point, ModivCare has a negative expected return of -0.0388%. Please make sure to verify ModivCare's value at risk, and the relationship between the jensen alpha and skewness , to decide if ModivCare performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days ModivCare has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable fundamental indicators, ModivCare is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors. ...more
Actual Historical Performance (%)
One Day Return 1.8 | Five Day Return 16.76 | Year To Date Return (59.22) | Ten Year Return (49.64) | All Time Return 31.23 |
Last Split Factor 1:3 | Last Split Date 2021-02-01 |
1 | Disposition of 1231 shares by Henry Toledo of ModivCare at 31.38 subject to Rule 16b-3 | 09/05/2024 |
2 | Acquisition by Coliseum Capital Management, Llc of 96441 shares of ModivCare at 29.25 subject to Rule 16b-3 | 09/06/2024 |
3 | Acquisition by Q Global Capital Management, L.p. of 20556 shares of ModivCare at 14.65 subject to Rule 16b-3 | 10/25/2024 |
4 | ModivCare Inc. Major Shareholder Q Global Capital Management, L Purchases 38,292 Shares | 11/01/2024 |
5 | Providence Real Estate Announces Sale of The Portofino Apartments in Tampa, Florida | 11/07/2024 |
6 | Hampton to visit Providence Tuesday | 11/12/2024 |
7 | Providence defeats Hampton 60-51 | 11/13/2024 |
8 | Providence Cancer Institute announces top leadership change | 11/14/2024 |
9 | Providence hosts Delaware State after Smiths 22-point showing | 11/18/2024 |
10 | Smith leads Delaware State against Providence after 22-point outing | 11/19/2024 |
11 | Providence names new COO | 11/20/2024 |
12 | Acquisition by Q Global Capital Management, L.p. of 13412 shares of ModivCare at 16.49 subject to Rule 16b-3 | 11/21/2024 |
13 | ModivCare Inc Trading 3.41 percent Higher on Nov 22 | 11/22/2024 |
Begin Period Cash Flow | 15 M |
ModivCare |
ModivCare Relative Risk vs. Return Landscape
If you would invest 2,702 in ModivCare on August 28, 2024 and sell it today you would lose (926.00) from holding ModivCare or give up 34.27% of portfolio value over 90 days. ModivCare is currently does not generate positive expected returns and assumes 9.334% risk (volatility on return distribution) over the 90 days horizon. In different words, 83% of stocks are less volatile than ModivCare, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
Risk |
ModivCare Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ModivCare's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as ModivCare, and traders can use it to determine the average amount a ModivCare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0042
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | MODV |
Estimated Market Risk
9.33 actual daily | 83 83% of assets are less volatile |
Expected Return
-0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average ModivCare is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ModivCare by adding ModivCare to a well-diversified portfolio.
ModivCare Fundamentals Growth
ModivCare Stock prices reflect investors' perceptions of the future prospects and financial health of ModivCare, and ModivCare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ModivCare Stock performance.
Return On Equity | -2.58 | ||||
Return On Asset | 0.0086 | ||||
Profit Margin | (0.07) % | ||||
Operating Margin | 0.01 % | ||||
Current Valuation | 1.47 B | ||||
Shares Outstanding | 14.28 M | ||||
Price To Earning | 52.70 X | ||||
Price To Book | 19.01 X | ||||
Price To Sales | 0.09 X | ||||
Revenue | 2.75 B | ||||
Gross Profit | 472.32 M | ||||
EBITDA | (26.75 M) | ||||
Net Income | (204.46 M) | ||||
Cash And Equivalents | 72.7 M | ||||
Cash Per Share | 5.14 X | ||||
Total Debt | 1.14 B | ||||
Debt To Equity | 2.88 % | ||||
Current Ratio | 0.71 X | ||||
Book Value Per Share | (1.19) X | ||||
Cash Flow From Operations | (82.97 M) | ||||
Earnings Per Share | (12.87) X | ||||
Market Capitalization | 254.11 M | ||||
Total Asset | 1.77 B | ||||
Retained Earnings | (24.44 M) | ||||
Working Capital | (115.48 M) | ||||
About ModivCare Performance
Evaluating ModivCare's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if ModivCare has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if ModivCare has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Days Of Inventory On Hand | 0.42 | 0.40 | |
Return On Tangible Assets | (0.33) | (0.31) | |
Return On Capital Employed | (0.11) | (0.11) | |
Return On Assets | (0.12) | (0.11) | |
Return On Equity | (1.31) | (1.24) |
Things to note about ModivCare performance evaluation
Checking the ongoing alerts about ModivCare for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ModivCare help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.ModivCare generated a negative expected return over the last 90 days | |
ModivCare has high historical volatility and very poor performance | |
ModivCare has high likelihood to experience some financial distress in the next 2 years | |
ModivCare currently holds 1.14 B in liabilities with Debt to Equity (D/E) ratio of 2.88, implying the company greatly relies on financing operations through barrowing. ModivCare has a current ratio of 0.7, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about ModivCare's use of debt, we should always consider it together with its cash and equity. | |
The entity reported the previous year's revenue of 2.75 B. Net Loss for the year was (204.46 M) with profit before overhead, payroll, taxes, and interest of 472.32 M. | |
ModivCare currently holds about 72.7 M in cash with (82.97 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.14. | |
ModivCare has a poor financial position based on the latest SEC disclosures | |
Over 99.0% of ModivCare shares are owned by institutional investors | |
Latest headline from gurufocus.com: ModivCare Inc Trading 3.41 percent Higher on Nov 22 |
- Analyzing ModivCare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ModivCare's stock is overvalued or undervalued compared to its peers.
- Examining ModivCare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ModivCare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ModivCare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ModivCare's stock. These opinions can provide insight into ModivCare's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for ModivCare Stock Analysis
When running ModivCare's price analysis, check to measure ModivCare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ModivCare is operating at the current time. Most of ModivCare's value examination focuses on studying past and present price action to predict the probability of ModivCare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ModivCare's price. Additionally, you may evaluate how the addition of ModivCare to your portfolios can decrease your overall portfolio volatility.